Transforming a highly toxic agent DM1 into injectable safe nanomedicines via prodrug self-assembly for the treatment of taxane-resistant cancer

Through a PUFA strategy, highly toxic DM1 was transformed into a safe self-assemble nanoprodrug, which had low systemic toxicity and could be used to treat taxane-resistant cervical cancer.